A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC

NCT05991206 · clinicaltrials.gov ↗
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Hunan Province Tumor Hospital